Diarrhea in kidney transplant recipients: Etiology and outcome.


Journal

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology
ISSN: 0975-0711
Titre abrégé: Indian J Gastroenterol
Pays: India
ID NLM: 8409436

Informations de publication

Date de publication:
04 2020
Historique:
received: 21 08 2018
accepted: 04 02 2020
pubmed: 1 5 2020
medline: 11 11 2020
entrez: 1 5 2020
Statut: ppublish

Résumé

Diarrhea in kidney transplant recipients influences outcome of transplantation. Data from India in this regard are sparse and do not address the differential outcome of infective and non-infective diarrhea. We studied the demographic data, laboratory findings, treatment response, disease duration, and outcome of diarrhea in kidney transplant recipients, and the differential outcome between infective and non-infective diarrhea, if any. All kidney transplant recipients who were referred to the Division of Gastroenterology with diarrhea between June 2015 and February 2017 were prospectively included. Demographic, clinical and laboratory data, graft function, treatment administered, and outcome were noted, and the patients were followed up for 3 months. Forty-seven patients (median age 45 years, range 16-78; 34 men) with 64 episodes of diarrhea were studied. Thirty-three (51.5%) episodes were attributed to infections. Eleven (17%) were immunosuppressant-induced (mycophenolate 8, tacrolimus 2, cyclosporine 1). Twenty (31%) were due to other causes (antibiotics 6, laxatives 3, irritable bowel syndrome 3, sepsis 8). Fifty-three episodes (82%) had graft dysfunction during the diarrheal episodes. Mean increase in serum creatinine was 45% in the infectious diarrhea group and 95% in the non-infectious diarrhea group (p < 0.05). Median time to resolution of diarrhea was 3 days. With improvement in diarrhea, return to pre-diarrhea creatinine levels occurred in 87% of episodes at 3 months. One-half of episodes of diarrhea in kidney transplant recipients were non-infectious in origin. Seventeen percent were attributed to immunosuppressants, requiring dose modification. More than 80% were associated with worsening of graft function. Recovery of graft function to baseline was seen in a majority of cases with the resolution of diarrhea.

Sections du résumé

BACKGROUND AND AIM
Diarrhea in kidney transplant recipients influences outcome of transplantation. Data from India in this regard are sparse and do not address the differential outcome of infective and non-infective diarrhea. We studied the demographic data, laboratory findings, treatment response, disease duration, and outcome of diarrhea in kidney transplant recipients, and the differential outcome between infective and non-infective diarrhea, if any.
METHODS
All kidney transplant recipients who were referred to the Division of Gastroenterology with diarrhea between June 2015 and February 2017 were prospectively included. Demographic, clinical and laboratory data, graft function, treatment administered, and outcome were noted, and the patients were followed up for 3 months.
RESULTS
Forty-seven patients (median age 45 years, range 16-78; 34 men) with 64 episodes of diarrhea were studied. Thirty-three (51.5%) episodes were attributed to infections. Eleven (17%) were immunosuppressant-induced (mycophenolate 8, tacrolimus 2, cyclosporine 1). Twenty (31%) were due to other causes (antibiotics 6, laxatives 3, irritable bowel syndrome 3, sepsis 8). Fifty-three episodes (82%) had graft dysfunction during the diarrheal episodes. Mean increase in serum creatinine was 45% in the infectious diarrhea group and 95% in the non-infectious diarrhea group (p < 0.05). Median time to resolution of diarrhea was 3 days. With improvement in diarrhea, return to pre-diarrhea creatinine levels occurred in 87% of episodes at 3 months.
CONCLUSION
One-half of episodes of diarrhea in kidney transplant recipients were non-infectious in origin. Seventeen percent were attributed to immunosuppressants, requiring dose modification. More than 80% were associated with worsening of graft function. Recovery of graft function to baseline was seen in a majority of cases with the resolution of diarrhea.

Identifiants

pubmed: 32350724
doi: 10.1007/s12664-020-01022-1
pii: 10.1007/s12664-020-01022-1
doi:

Substances chimiques

Anti-Bacterial Agents 0
Immunosuppressive Agents 0
Laxatives 0
Tacrolimus WM0HAQ4WNM

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

141-146

Auteurs

Ajinkya Sonambekar (A)

Division of Gastroenterology, P D Hinduja Hospital, Mahim, Mumbai, 400 016, India.

Vatsal Mehta (V)

Division of Gastroenterology, P D Hinduja Hospital, Mahim, Mumbai, 400 016, India.

Devendra Desai (D)

Division of Gastroenterology, P D Hinduja Hospital, Mahim, Mumbai, 400 016, India. devendracdesai@gmail.com.

Philip Abraham (P)

Division of Gastroenterology, P D Hinduja Hospital, Mahim, Mumbai, 400 016, India.

Alan Almeida (A)

Division of Nephrology, P D Hinduja Hospital, Mahim, Mumbai, 400 016, India.

Anand Joshi (A)

Division of Gastroenterology, P D Hinduja Hospital, Mahim, Mumbai, 400 016, India.

Tarun Gupta (T)

Division of Gastroenterology, P D Hinduja Hospital, Mahim, Mumbai, 400 016, India.

Rasika Sirsat (R)

Division of Nephrology, P D Hinduja Hospital, Mahim, Mumbai, 400 016, India.

Jatin Kothari (J)

Division of Nephrology, P D Hinduja Hospital, Mahim, Mumbai, 400 016, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH